H. M. van Praag (1978). Amine hypothesis of affective disorders. In: L. L. Iversen, S. D. Iversen,
S. H. Snyder (Eds.). HandbookofPsychopharmacology, vol. 13. New York: Plenum Press,
pp. 187–297.
Serotonin and Serotonin Receptors
D. N. Bateman (1993). Sumatriptan. Lancet. 341: 221.
D. Deleu, Y. Hanssens, E. A. Worthing (1998). Symptomatic and prophylactic treatment of
migraine.Clin. Neuropharmacol. 21: 267.
M. Dukat (2004). 5-HT3 serotonin receptor agonists: a pharmacophoric journey. Curr. Med.
Chem.:CNS Agents 4: 77–94.
W. B. Essman (Ed.) (1978). Serotonin in Health and Disease, 5 vols. New York: Spectrum.
J. R. Fozard (1987). 5-HT 3 receptors and cytotoxic drug-induced vomiting. Trends Pharmacol.
Sci. 8 : 44–45.
J. R. Fozard, H. O. Kalkman (1994). 5-Hydroxytryptamine and the initiation of migraine: new
perspectives. Naunyn-Schmiedebergs Arch. Pharmacol. 350: 225.
R. W. Fuller (1990). Pharmacology of central serotoninergic neurons. Annu. Rev. Pharmacol.
Toxicol. 20 : 111–127.
J. C. Gillin, W. B. Mendelson, N. Sitaram, R. J. Wyatt (1978). The neuropharmacology of sleep
and wakefulness. Annu. Rev. Pharmacol. Toxicol. 18: 563–579.
R. A. Glennon (1987). Central serotonin receptors as targets for drug research. J. Med. Chem. 30:
1–12.
R. A. Glennon (2003). Higher-end serotonin receptors: 5-HT5, 5-HT6, and 5-HT7. J. Med. Chem.
46 : 2795–2812.
R. A. Glennon, M. Dukat (1995). Serotonin receptor subtypes. In: F. Bloom, D. Kupfer (Eds.).
Psychopharmacology:The Fourth Generation of Progress.New York: Raven Press.
M. Gothert (1982). Modulation of serotonin release in the brain via presynaptic receptors. Trends
Pharmacol. Sci. 3: 437–440.
A. R. Green (1985). Neuropharmacology of Serotonin. New York: Oxford University Press.
L. Gyermek (1995). 5-HT3 receptors: pharmacologic and therapeutic aspects. J. Clin.
Pharmacol. 35: 845.
S. Inoué, A. A. Borbély (1985). Endogenous Sleep Substances and Sleep Regulation. Utrecht:
VNU Science Press.
D. Julius (1991). Molecular biology of serotonin receptors. Ann. Rev. Neurosci. 14: 335.
J. M. Krueger (1985). Somnogenic activity of muramyl peptides. Trends Pharmacol. Sci. 6:
218–221.
M. Lejoyeux, J. Ades, F. Rouillon (1994). Serotonin syndrome: incidence, symptoms and treat-
ment.CNS Drugs 2: 132.
D. N. Middlemiss, M. Hibert, J. R. Fozard (1986). Drugs acting at central 5-hydroxytryptamine
receptors.Annu. Rep. Med. Chem. 21 : 41–50.
T. Nogrady, P. D. Hrdina, G. M. Ling (1972). Investigation of serotonin–ATP association in vitro
by NMR and UV spectroscopy. Mol. Pharmacol. 8: 565–577.
S. J. Peroutka (1995). Serotonin receptor subtypes: Their evolution and clinical significance. CNS
Drugs 4: 19.
S. J. Peroutka, R. M. Lebovitz, S. H. Snyder (1981). Two distinct central serotonin receptors with
different physiological functions. Science 212: 827–829.
B. P. Richardson, G. Engel (1986). The pharmacology and function of 5–HT 3 receptors.Trends
Neurosci. 9: 424–428.
304 MEDICINAL CHEMISTRY